CONSENT OF RICHARD A. EISNER & CO
Published on August 5, 1999
EXHIBIT 23.2
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to inclusion in this Post-Effective Amendment No. 7 to the
Registration Statement on Form SB-2 of our report dated February 6, 1999 on our
audits of the financial statements of Cytoclonal Pharmaceutics Inc., a Delaware
corporation, as of December 31, 1998 and 1997 and for each of the years in the
three-year period ended December 31, 1998. We also consent to the reference of
our firm under the captions "Experts" and "Selected Financial Data" in the
Prospectus.
/s/ Richard A. Eisner & Company, LLP
- ------------------------------------
Richard A. Eisner & Company, LLP
New York, New York
August 5, 1999